Aera Therapeutics
Enabling the next generation of transformative genetic medicines
88 employees · est. 2021 · Cambridge, United States
Aro Biotherapeutics is the older company (2021 vs 2018).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Aera Therapeutics | Aro Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Philadelphia, United States |
| Employees | ||
| Employees | 88 | 51 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Series B |
| Total Funding | ||
| Total Funding | $58.00M | $166.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Development of genetic medicine delivery platforms, Research and innovation in genetic therapies, Enhancing delivery technologies for therapeutic applications | Development of Centyrin-based Therapeutic Candidates, Research and Optimization of Receptor-specific Centyrins, Conjugation of Centyrins to Oligonucleotides |
| Target Customers | ||
| Target Customers | Biopharmaceutical companies, Healthcare providers, Medical research institutions, Patients with unmet therapeutic needs | Patients with Genetic Disorders, Biotechnology Industry Partners, Researchers in Genetic Medicine |
| Taxonomy | ||
| Taxonomy | Genetic Medicines, Delivery Platforms, Lipid Nanoparticles, Antibody Oligonucleotide Conjugates, Protein Nanoparticles, Therapeutic Modalities, Endogenous Human Proteins, Gene-editing Enzymes, Therapeutic Enzyme Platform, Targeted Delivery, Novel Delivery Technologies, Disease Treatment, Transformative Genetic Therapies | Genetic Medicines, Tissue-targeted Therapies, Philadelphia, Centyrins, Therapeutic Candidates, Proprietary Protein Technology, Disease Therapies, Drug Development, Biopharmaceuticals, Industry Partnerships, Disease Targeting, Genetic Medicine Innovation |
| Website | ||
| Website | aeratx.com | arobiotx.com |
About Aera Therapeutics
Aera Therapeutics, founded in 2021, is a pioneering entity in the Biotechnology and Pharmaceutical industries. Headquartered in the United States, the company's slogan, "Enabling the next generation of transformative genetic medicines," accurately encapsulates its mission. The firm aims to address...
About Aro Biotherapeutics
Aro Biotherapeutics, founded in 2018 and headquartered in the United States, is at the forefront of biotechnology innovation. The company specializes in developing tissue-targeted genetic medicines, leveraging its proprietary Centyrins technology. This platform is propelling the creation of a robust...
We will tell you when either one moves
BounceWatch watches Aera Therapeutics and Aro Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aera Therapeutics and Aro Biotherapeutics — by email.
Frequently Asked Questions
Compare Aera Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Aera Therapeutics on 15 Jun 2026, and Aro Biotherapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
